Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic and clinicopathological value of CDK12 mutation in prostate cancer: a meta-analysis.

Expert review of anticancer therapy - 1 Feb 2023

Zhang Wenjian, Zhou Lushan, Di Jianzhong

Abstract excerpt

BACKGROUND: Cyclin-dependent kinase 12 (CDK12) mutation has been shown to be associated with the prognosis and clinicopathological characteristics of various tumors. The aim of this meta-analysis was to investigate the role of mutations in prostate cancer (PCa). RESEARCH DESIGN AND METHODS: PubMed/Medline, EMBASE, Cochrane Library, and Web of Science database were searched for relevant articles. Meta-analysis was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Cyclin-Dependent Kinases
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prognosis

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 36734254
DOI: 10.1080/14737140.2023.2168647

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic and clinicopathological value of CDK12 mutation in prostate cancer: a meta-analysis.PMID 36734254Read ↗

Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced Prostate Cancer.Semantic proximity Read ↗

Prognostic value of genomic mutations in metastatic prostate cancerSemantic proximity Read ↗

Evaluation of the Prognostic Role of TP53 Gene Mutations in Prostate Cancer Outcome: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Characterizing CDK12-Mutated Prostate CancersSemantic proximity Read ↗

BRCA2 mutations should be screened early and routinely as markers of poor prognosis: evidence from 8,988 patients with prostate cancerSemantic proximity Read ↗

A Systematic Review and Meta-Analysis of Three Gene Variants Association with Risk of Prostate Cancer: An Update.Semantic proximity Read ↗

Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancerSemantic proximity Read ↗

Molecular Characterization of KRAS, BRAF, and EGFR Genes in Cases with Prostatic Adenocarcinoma; Reporting Bioinformatics Description and Recurrent Mutations.Semantic proximity Read ↗

TP53 alterations of hormone-naïve prostate cancer in the Chinese population.Semantic proximity Read ↗

[Clinical features and prognostic value of TP53 mutation in Chinese prostate cancer patients].Semantic proximity Read ↗

Are cell cycle and apoptosis genes associated with prostate cancer risk in North Indian population?Semantic proximity Read ↗

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.